David Stack, Pacira CEO

Af­ter buy­ing out Flex­ion for $450M, Paci­ra qui­et­ly lays off 110 of its em­ploy­ees

Af­ter be­ing ac­quired by Paci­ra Bio­sciences in a $450 mil­lion deal, it looks like Flex­ion Ther­a­peu­tics qui­et­ly brought out the axe.

While de­tails re­main few …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.